TMB-H (>= 10 mutations / Mb)
About
Biomarker type: Tumor mutational burden
Classification: High
Minimum mutations per megabase: 10
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | TMB-H (>= 10 mutations / Mb) | Any solid tumor | Pembrolizumab |